Laurus Labs Ltd announced that its subsidiary, Laurus Bio, has signed a definitive agreement for an equity investment of ₹ 120 Cr from our India Ventures team and F-Prime Capital. Laurus Labs will also co-invest an additional ₹ 40 Cr at the same valuation.

Laurus Bio has over a decade’s experience in precision fermentation and recombinant DNA technology. The animal-origin-free recombinant protein maker offers precision fermentation expertise as a CDMO service to novel protein companies and bio-manufacturers across healthcare, and bio-based materials markets.

Dr. Satyanarayana Chava, Founder & CEO of Laurus Labs and Rajesh Krishnamurthy, CEO of Laurus Bio commented: “We are pleased to announce rejoining the partnership with Eight Roads Ventures and Laurus Lab’s continued commitment with an additional investment into Laurus Bio. The Company, promoters of Laurus Bio, Eight Roads Ventures and F-Prime Capital will drive expansion of the manufacturing and R&D infrastructure to further accelerate growth opportunities.  Eight Roads Ventures brings a global network, relevant industry experience and a strong track record of biopharmaceuticals and CDMO investing.  This investment will enable the company to further expand and accelerate microbial-fermentation capabilities, including faster development of new products, speed-up internal pipeline, enhancing high quality commercial-scale capacity to partners and growing our industry position.”

Dr. Prem Pavoor, Managing Partner, Eight Roads Ventures India, said “We are thrilled to re-unite with two of our former partners – Laurus Labs & Laurus Bio (formerly Richcore Lifesciences) who have built a best-in-class biomanufacturing platform to cater to the growing global demand for sustainable manufacturing technologies. Biomanufacturing is already being utilized across a range of industries including personal care, materials, food and nutrition and pharmaceuticals. We are looking forward to growing Laurus Bio into a global leader in this emerging segment.”

Laurus Bio will use the funds for expanding its fermentation-based manufacturing capabilities to cater to its growing demand.

Read more about this partnership here.